Ohio State is in the process of revising websites and program materials to accurately reflect compliance with the law. While this work occurs, language referencing protected class status or other activities prohibited by Ohio Senate Bill 1 may still appear in some places. However, all programs and activities are being administered in compliance with federal and state law.

Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis

Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis

Investigators

Patrick G Dougherty
Jack H Wellmerling
Amritendu Koley
Jessica K Lukowski
Amanda B Hummon
Estelle Cormet-Boyaka
Dehua Pei

Filters: 2020